Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo
Authors:
- Linda ZaneLZLinda Zane
- David SibonDSDavid Sibon
- Lionel JeanninLJLionel Jeannin
- Marc ZandeckiMZMarc Zandecki
- Marie-Hélène Delfau-LarueMDMarie-Hélène Delfau-Larue
- Antoine GessainAGAntoine Gessain
- Olivier GoutOGOlivier Gout
- Christiane PinatelCPChristiane Pinatel
- Agnès LançonALAgnès Lançon
- Franck MortreuxFMFranck Mortreux
- Eric WattelEWEric Wattel
Open Access
- 11 March 2010
- journal article
- research article
- Published by Springer Nature in Retrovirology
- Vol. 7 (1) , 17
Abstract
Background: Adult T cell leukemia results from the malignant transformation of a CD4+ lymphoid clone carrying an integrated HTLV-1 provirus that has undergone several oncogenic events over a 30-60 year period of persistent clonal expansion. Both CD4+ and CD8+ lymphocytes are infected in vivo; their expansion relies on CD4+ cell cycling and on the prevention of CD8+ cell death. Cloned infected CD4+ but not CD8+ T cells from patients without malignancy also add up nuclear and mitotic defects typical of genetic instability related to theexpression of the virus-encoded oncogene tax. HTLV-1 expression is cancer-prone in vitro, but in vivo numerous selection forces act to maintain T cell homeostasis and are possibly involved in clonal selection. Results: Here we demonstrate that the HTLV-1 associated CD4+ preleukemic phenotype and the specific patterns of CD4+ and CD8+ clonal expansion are in vivo selected processes. By comparing the effects of recent (1 month) experimental infections performed in vitro and those observed in cloned T cells from patients infected for >6-26 years, we found that in chronically HTLV-1 infected individuals, HTLV-1 positive clones are selected for tax expression. In vivo, infected CD4+ cells are positively selected for cell cycling whereas infected CD8+ cells and uninfected CD4+ cells are negatively selected for the same processes. In contrast, the known HTLV-1-dependent prevention of CD8+ T cell death pertains to both in vivo and in vitro infected cells. Conclusions: Therefore, virus-cell interactions alone are not sufficient to initiate early leukemogenesis in vivo.Keywords
This publication has 37 references indexed in Scilit:
- Inhibitors of Strand Transfer That Prevent Integration and Inhibit Human T-Cell Leukemia Virus Type 1 Early ReplicationAntimicrobial Agents and Chemotherapy, 2008
- The HTLV-1 Tax interactomeRetrovirology, 2008
- HTLV-1 Integration into Transcriptionally Active Genomic Regions Is Associated with Proviral Expression and with HAM/TSPPLOS Pathogens, 2008
- Early and transient reverse transcription during primary deltaretroviral infection of sheepRetrovirology, 2008
- HTLV-1 propels untransformed CD4+ lymphocytes into the cell cycle while protecting CD8+ cells from deathJournal of Clinical Investigation, 2006
- Fate of Premalignant Clones during the Asymptomatic Phase Preceding Lymphoid MalignancyCancer Research, 2005
- Common Human T Cell Leukemia Virus Type 1 (HTLV‐1) Integration Sites in Cerebrospinal Fluid and Blood Lymphocytes of Patients with HTLV‐1–Associated Myelopathy/Tropical Spastic Paraparesis Indicate that HTLV‐1 Crosses the Blood‐Brain Barrier via Clonal HTLV‐1–Infected CellsThe Journal of Infectious Diseases, 2000
- Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCRResearch in Virology, 1995
- HTLV-I Trans-Activator Protein, Tax, is a Trans-Repressor of the Human β-Polymerase GgeneScience, 1990
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISThe Lancet, 1985